Global Metabolic Partnering 2010-2016: Deal trends, players and financials
Global Cancer Diagnostics Partnering 2010-2015: Deal trends, players, financials and forecasts
-
Upload
market-research-reports-inc -
Category
Healthcare
-
view
101 -
download
0
Transcript of Global Cancer Diagnostics Partnering 2010-2015: Deal trends, players, financials and forecasts
www.MarketResearchReports.com
Global Cancer Diagnostics Partnering 2010-2015: Deal trends,
players, financials and
forecasts
Category : Healthcare
All logos and Images mentioned on this slide belong to their respective owners.
www.MarketResearchReports.com
Introduction to Report
Launch Date: July 1, 2015
Number of Pages: 1937
Geography Coverage: Global
Available Format: PDF
Price For Single User License: USD 2,995
Price For Site User License: USD 8,995
Price For Global User License: USD 14,995
Delivery Time: Within 24 Hours (During Working Days)
www.MarketResearchReports.com
About the Report
Global Cancer Diagnostics (GCD) Partnering 2010-2015 report provides an understanding and access to the cancer diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies.
The report provides an understanding and analysis of how and why companies enter cancer diagnostics partnering deals.
The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors diagnostics technology.
www.MarketResearchReports.com
Key Findings:
This report contains over 1,000 links to online copies of actual cancer diagnostics deals and where available, contract documents as submitted to the Securities Exchange Commission by companies and their partners.
Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.
The report takes readers through the comprehensive cancer diagnostics deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering cancer diagnostics partnering deals.
www.MarketResearchReports.com
Key Findings: Continue…
The report presents average financial deal terms values for cancer diagnostics deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.
The middle section of the report explores the leaders in the cancer diagnostics partnering field; both the leading deal values and leading players are reported allowing readers to see who is succeeding in this growing market.
This chapter also looks at the contributions by the big pharma and big biotech companies of the world in terms of deals made.
www.MarketResearchReports.com
GCD Partnering 2010-2015 includes:
Trends in cancer diagnostics dealmaking in the biopharma industry since 2010
Analysis of cancer diagnostics deal structure
Access to headline, upfront, milestone and royalty data
Access to over 1,000 cancer diagnostics deal records
The leading cancer diagnostics deals by value since 2010
Includes companion, imaging, CT, MRI, ultrasound, in vitro, molecular, prognostics and theranostics diagnostics deals and alliances since 2010
www.MarketResearchReports.com
Benefits:
In-depth understanding of cancer diagnostics deal trends since 2010
Access to headline, upfront, milestone and royalty data
Access to the structure of cancer diagnostics agreements with numerous real life case studies
Comprehensive access to over 1,000 actual cancer diagnostics deals entered into by the world’s biopharma companies, together with real world clause examples
Full listing of cancer diagnostics deals by company A-Z, deal value, phase of development, deal type, and therapy focus
Identify leading cancer diagnostics deals by value since 2009
www.MarketResearchReports.com
Benefits: Continue…
Identify the most active cancer diagnostics dealmakers since 2010
Understand the key deal terms companies have agreed in previous deals
Undertake due diligence to assess suitability of your proposed deal terms for partner companies
www.MarketResearchReports.com
Report Coverage:
1. Executive Summary
2. Introduction
3. Average financial deal terms for cancer diagnostics partnering
4. Leading cancer diagnostics deals
5. Cancer diagnostics dealmaking contracts directory
6. Cancer diagnostics dealmaking by specific therapy type
7. Cancer diagnostics dealmaking by specific technology type
8. Future trends and companies in cancer diagnostics deal making
For more details regarding Report coverage see the last slideAll logos and Images mentioned on this slide belong to their respective owners.
www.MarketResearchReports.com
Report Coverage: Continues…
9. Partnering resource center
10. Appendices
For more details regarding Report coverage see the last slideAll logos and Images mentioned on this slide belong to their respective owners.
www.MarketResearchReports.com
Custom Research: Are you an industry professional, entrepreneur,
venture capitalist, investors and organization, then let us know your specific research requirements. Our goal is to cater to your requirements be it for a custom market research project, syndicated research report on a specific market or industry sector, newsletter creation, case study development or anything else related to marketing research.
For Any Customization Related query Visit IdeaCenter @http://www.marketresearchreports.com/idea-center
For regular industry updates subscribe to our newsletter at: http://www.marketresearchreports.com/subscribe-to-newsletter
www.MarketResearchReports.com
How To Buy This Report?
Visit following URL to see Table of Content and purchase this publication:
http://mrr.cm/4E2
About Market Research Reports, Inc.Market Research Reports provides a customized set of reports from reputed Publishers, built on the intelligence available within organizations and leverages on our motto of “Intelligence Redefined”.
Contact : Amitava SenEmail : [email protected]: +1 302-703-7787 (USA) +91-8762746600 (India)